Testing effectiveness (Phase 2)WithdrawnNCT00562055
What this trial is testing
Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.
Who this might be right for
Attention Deficit Hyperactivity Disorder
Pfizer